potassium voltage-gated channel subfamily A member 5
RGD ID:
2953
Description:
Enables delayed rectifier potassium channel activity; outward rectifier potassium channel activity; and signaling receptor binding activity. Involved in several processes, including positive regulation of G1/S transition of mitotic cell cycle; positive regulation of myoblast proliferation; and potassium ion export across plasma membrane. Located in several cellular components, including Z disc; intercalated disc; and intracellular canaliculus. Part of voltage-gated potassium channel complex. Used to study pulmonary hypertension. Biomarker of hypertension. Human ortholog(s) of this gene implicated in familial atrial fibrillation and pulmonary hypertension. Orthologous to human KCNA5 (potassium voltage-gated channel subfamily A member 5); PARTICIPATES IN acebutolol pharmacodynamics pathway; adrenergic beta receptor agonist and beta-blocker pharmacodynamics pathway; amiodarone pharmacodynamics pathway; INTERACTS WITH (5Z,8Z,11Z,13E)-15-HETE; 1-naphthyl isothiocyanate; allethrin.
Kv1; Kv1.5; potassium (K+) channel protein alpha 5; potassium channel, voltage gated shaker related subfamily A, member 5; potassium voltage gated channel shaker related subfamily member 5; potassium voltage gated channel, shaker related subfamily, member 5; potassium voltage-gated channel, shaker-related subfamily, member 5; RCK7; RK4; voltage-gated potassium channel subunit Kv1.5
Rotenone inhibits the reaction [Acrolein results in increased expression of KCNA5 mRNA] and Rotenone inhibits the reaction [Acrolein results in increased expression of KCNA5 protein]
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of KCNA5 protein
(2-isopropyl-5-methylcyclohexyl) diphenylphosphine oxide inhibits the reaction [Apigenin inhibits the reaction [Oxygen deficiency results in decreased expression of KCNA5 protein]] more ...
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of KCNA5 protein
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of KCNA5 protein
(2-isopropyl-5-methylcyclohexyl) diphenylphosphine oxide inhibits the reaction [Apigenin inhibits the reaction [Oxygen deficiency results in decreased expression of KCNA5 protein]] more ...
[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KCNA5 mRNA
ferrostatin-1 inhibits the reaction [Ethanol results in decreased expression of KCNA5 mRNA] and ferrostatin-1 inhibits the reaction [Ethanol results in decreased expression of KCNA5 protein]
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of KCNA5 protein
ferrostatin-1 inhibits the reaction [Ethanol results in decreased expression of KCNA5 mRNA] and ferrostatin-1 inhibits the reaction [Ethanol results in decreased expression of KCNA5 protein]
Masoprocol inhibits the reaction [[[Oxygen deficiency results in increased activity of ALOX15 protein] which results in increased chemical synthesis of 15-hydroxy-5 more ...
[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KCNA5 mRNA
Rotenone inhibits the reaction [Acrolein results in increased expression of KCNA5 mRNA] and Rotenone inhibits the reaction [Acrolein results in increased expression of KCNA5 protein]
[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KCNA5 mRNA
An abnormal mitochondrial-hypoxia inducible factor-1alpha-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities to human pulmonary arterial hypertension.
Serotonin inhibits voltage-gated K+ currents in pulmonary artery smooth muscle cells: role of 5-HT2A receptors, caveolin-1, and KV1.5 channel internalization.
expression induced by platelet-derived growth factor (Pdgf) and basic fibroblast growth factor and is accompanied by increased delayed rectifier current (IK),an indicator of mitogenesis